Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Moleculin Biotech, Inc. (MBRX)

1.0300
-0.0200
(-1.90%)
At close: April 23 at 4:00:01 PM EDT
1.0400
+0.01
+(0.97%)
Pre-Market: 6:27:55 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
26,641
26,641
29,631
30,640
22,968
Operating Income
-26,641
-26,641
-29,631
-30,640
-22,968
Net Non Operating Interest Income Expense
550
550
1,368
240
306
Other Income Expense
4,328
4,328
-1,506
1,375
6,768
Pretax Income
-21,763
-21,763
-29,769
-29,025
-15,894
Net Income Common Stockholders
-21,763
-21,763
-29,769
-29,025
-15,894
Diluted NI Available to Com Stockholders
-21,763
-21,763
-29,769
-29,025
-15,894
Basic EPS
-6.32
--
-15.07
-15.15
-8.85
Diluted EPS
-6.32
--
-15.07
-15.15
-8.85
Basic Average Shares
3,442.9970
--
1,975.6100
1,906.9590
1,791.7280
Diluted Average Shares
3,442.9970
--
1,975.6100
1,906.9590
1,791.7280
Total Operating Income as Reported
-26,641
-26,641
-29,631
-30,640
-22,968
Total Expenses
26,641
26,641
29,631
30,640
22,968
Net Income from Continuing & Discontinued Operation
-21,763
-21,763
-29,769
-29,025
-15,894
Normalized Income
-27,888
-27,888
-28,725
-30,360
-22,622
Interest Income
550
550
1,368
240
306
Net Interest Income
550
550
1,368
240
306
EBIT
-26,641
-26,641
-29,631
-30,640
-22,968
EBITDA
-26,515
-26,515
-29,504
-30,510
-22,804
Reconciled Depreciation
126
126
127
130
164
Net Income from Continuing Operation Net Minority Interest
-21,763
-21,763
-29,769
-29,025
-15,894
Total Unusual Items Excluding Goodwill
6,125
6,125
-1,044
1,335
6,728
Total Unusual Items
6,125
6,125
-1,044
1,335
6,728
Normalized EBITDA
-32,640
-32,640
-28,460
-31,845
-29,532
12/31/2021 - 6/2/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CNSP CNS Pharmaceuticals, Inc.
0.9548
+7.04%
 
PHIO Phio Pharmaceuticals Corp.
2.0400
-18.73%
 
IVVD Invivyd, Inc.
0.6443
+4.61%
 
PSTV Plus Therapeutics, Inc.
0.9835
+24.97%
 
XLO Xilio Therapeutics, Inc.
0.7939
-1.99%
 
KTTA Pasithea Therapeutics Corp.
1.6300
+5.84%
 
RNAZ TransCode Therapeutics, Inc.
0.3140
+1.00%
 
EDSA Edesa Biotech, Inc.
2.3300
+1.30%
 
MIST Milestone Pharmaceuticals Inc.
1.1600
+9.43%
 
CAPR Capricor Therapeutics, Inc.
13.15
-5.33%